Janus Henderson Group PLC trimmed its position in Maximus, Inc. (NYSE:MMS – Free Report) by 95.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,701 shares of the health services provider’s stock after selling 493,848 shares during the period. Janus Henderson Group PLC’s holdings in Maximus were worth $1,519,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of MMS. Farther Finance Advisors LLC raised its stake in Maximus by 69.0% in the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after buying an additional 116 shares during the last quarter. Advisory Services Network LLC acquired a new stake in Maximus in the 3rd quarter worth approximately $32,000. Canada Pension Plan Investment Board acquired a new stake in Maximus in the 2nd quarter worth approximately $35,000. Northwestern Mutual Wealth Management Co. grew its position in Maximus by 225.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock worth $38,000 after purchasing an additional 304 shares during the last quarter. Finally, Richardson Financial Services Inc. grew its position in Maximus by 29.6% during the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock worth $39,000 after purchasing an additional 103 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.
Maximus News Summary
Here are the key news stories impacting Maximus this week:
- Positive Sentiment: Fiscal Q3 adjusted earnings were $2.22 per share, ahead of analyst estimates of approximately $2.20–$2.21 and up from $2.16 a year earlier. Higher margins also supported the quarter’s bottom-line performance. Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
- Positive Sentiment: The earnings beat, year-over-year EPS growth and stronger margins indicate that Maximus is maintaining profitability even as sales soften. Maximus Q3 Earnings Beat Estimates
- Neutral Sentiment: Management’s fiscal Q3 earnings call focused on the quarterly performance and updated outlook, providing investors with additional context on operating trends and the company’s expectations for the remainder of fiscal 2026. Maximus Q3 2026 Earnings Call Transcript
- Negative Sentiment: Revenue was $1.28 billion, below the $1.33 billion consensus estimate and down 5.1% year over year. The shortfall suggests softer demand or project timing is limiting growth. Maximus Fiscal Q3 Earnings Snapshot
- Negative Sentiment: Maximus reduced fiscal 2026 EPS guidance to $7.90–$8.20, below the consensus estimate of $8.43. Revenue guidance of $5.2–$5.4 billion remains broadly in line with expectations at the midpoint, but the lower profit outlook is a key overhang for MMS. Updated Maximus Fiscal 2026 Guidance
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on Maximus
Maximus Price Performance
Shares of NYSE:MMS opened at $59.21 on Monday. Maximus, Inc. has a twelve month low of $52.73 and a twelve month high of $100.00. The company’s 50 day moving average is $58.63 and its 200 day moving average is $67.24. The company has a current ratio of 2.42, a quick ratio of 2.42 and a debt-to-equity ratio of 0.90. The company has a market cap of $3.10 billion, a PE ratio of 8.75 and a beta of 0.59.
Maximus (NYSE:MMS – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, beating the consensus estimate of $2.21 by $0.01. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The business had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same period in the previous year, the business posted $2.16 EPS. The business’s quarterly revenue was down 5.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. On average, sell-side analysts forecast that Maximus, Inc. will post 8.05 EPS for the current year.
Maximus Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be given a dividend of $0.33 per share. The ex-dividend date is Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. Maximus’s payout ratio is currently 19.76%.
Maximus Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Further Reading
- Five stocks we like better than Maximus
- Albemarle’s Blowout Quarter Shows Why Lithium Still Matters
- Can DICK’S Turn Foot Locker Into a Winner?
- Why Dutch Bros Plunged Despite a Q2 Earnings Beat and Record Revenue
- Take-Two’s Q1 Results Leave GTA 6 Bulls Stuck in the Fog of War
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
